FIG 3.
Efficacy of human-simulated exposures of cefiderocol compared with same-period untreated controls at 24, 48, and 72 h among Enterobacteriaceae. Isolate cefiderocol preexposure MICs (μg/ml): K. pneumoniae 531, 4 (A); K. pneumoniae 519, 4 (B); E. coli 462, 1 (C). Absence of control data at any given interval indicates zero survival for that isolate.